XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”),
a health and wellness company, today announced that it has opened a
new COVID-19 testing facility at San Francisco International
Airport (SFO).
XpresCheck is a pop-up facility located
pre-security, near the baggage claim area on the Arrivals level at
Terminal 3. Nine separate testing rooms provide the capacity to
administer over 500 tests per day. COVID-19 testing options include
a Rapid Molecular COVID-19 Test, the standard Polymerase Chain
Reaction (PCR) Test, and a new Rapid PCR test in the near
future.
Doug Satzman, XpresSpa CEO, stated, "We are
delighted to launch XpresCheck at San Francisco International
Airport. Through our trusted relationship with United Airlines, we
can now offer travelers and airline employees convenient COVID-19
testing options at our on-site testing facility. Additionally,
several direct flights to Hawaii originate at SFO and we
are proud to be a trusted partner of Hawaiian
Airlines and the state of Hawaii. As airport traffic
continues to increase, we are pleased to be doing our part to make
everyone feel more comfortable through this additional layer of
safety.”
Lori Augustine, United Airlines’ Vice President
of Airport Operations at SFO, said, “We’re thrilled to offer United
customers traveling through San Francisco yet another testing
option – this time, conveniently located before security inside our
terminal – to help them meet the entry requirements at their final
destination. United customers will be able to easily upload their
test results into Travel-Ready Center and start their travel with
peace of mind.”
“We welcome the addition of an XpresCheck™
COVID-19 Pop-Up Testing Facility at SFO,” said Airport
Director Ivar C. Satero. “As the first airport in
the U.S. to launch an onsite rapid testing capability, we
understand the importance of giving travelers convenient on-airport
testing options. We thank both United Airlines and
the XpresSpa Group for bringing this concept to SFO.”
About XpresSpa Group, Inc.
XpresSpa Group, Inc. (Nasdaq: XSPA) is a leading
global health and wellness holding company. XpresSpa Group’s core
asset, XpresSpa, is a leading airport retailer of spa services and
related health and wellness products, with 45 locations in 23
airports globally. Through its XpresTest, Inc. subsidiary, the
Company provides COVID-19 screening and testing under the
XpresCheck™ brand at thirteen locations in eleven airports: Boston
Logan International Airport (2), Denver International Airport,
Dulles International Airport, George Bush Intercontinental Airport,
JFK International Airport, Newark Liberty International Airport
(2), Phoenix Sky Harbor International Airport, Reagan National
Airport, Salt Lake City International Airport, San Francisco
International Airport, and Seattle-Tacoma International Airport. To
learn more about XpresSpa Group, visit: www.XpresSpaGroup.com.
Twitter: @xprescheck and Instagram:
@realxprescheck
About United Airlines
United's shared purpose is "Connecting People.
Uniting the World." For more information, visit united.com, follow
@United on Twitter and Instagram or connect on Facebook. The common
stock of United's parent, United Airlines Holdings, Inc., is traded
on the Nasdaq under the symbol "UAL".
About San Francisco International
Airport
SFO wants you to Travel Well. SFO works with
local, state, and federal health officials to protect against
COVID-19. Measures include enhanced cleaning protocols, hundreds of
hand sanitizer stations, physical barriers, face coverings for
everyone, and physical distancing. To learn more visit
flysfo.com/travel-well.
SFO offers nonstop service to Asia, South
Pacific, Europe, Canada, Mexico, and across the United States. For
up-to-the-minute departure and arrival information, airport maps
and details on shopping, dining, cultural exhibitions, ground
transportation and more, visit www.flysfo.com. Follow us on
www.twitter.com/flysfo and www.facebook.com/flysfo.
Forward-Looking Statements
This press release may contain "forward-looking"
statements within the meaning of Section 27A of the Securities Act
of 1933, and Section 21E of the Securities Exchange Act of 1934.
These include statements preceded by, followed by or that otherwise
include the words "believes," "expects," "anticipates,"
"estimates," "projects," "intends," "should," "seeks," "future,"
"continue," or the negative of such terms, or other comparable
terminology. In particular, these statements include, without
limitation, statements about our expectations relating to our new
XpresCheck™ concept, being able to expand testing to other
communicable diseases as well as administer vaccinations for the
seasonal flu, our positioning to be part of the national rollout of
various COVID-19 vaccinations, the degree to which our public
testing model assists passengers meet testing requirements in
select states and countries, our ability to identify and gain
access to the latest and best COVID-19 testing methodologies and
equipment, and our overall ability to manage the regulatory
challenges associated with this business line. Forward-looking
statements relating to expectations about future results or events
are based upon information available to XpresSpa Group as of
today's date and are not guarantees of the future performance of
the company, and actual results may vary materially from the
results and expectations discussed. Additional information
concerning these and other risks is contained in XpresSpa Group’s
most recently filed Annual Report on Form 10-K, Quarterly Report on
Form 10-Q, recent Current Reports on Form 8-K and other Securities
and Exchange Commission filings. All subsequent written and oral
forward-looking statements concerning XpresSpa Group, or other
matters and attributable to XpresSpa Group or any person acting on
its behalf are expressly qualified in their entirety by the
cautionary statements above. XpresSpa Group does not undertake any
obligation to publicly update any of these forward-looking
statements to reflect events or circumstances that may arise after
the date hereof.
Investor Relations:ICRRaphael
Grossir@xpresspagroup.com(203) 682-8253
Media:Julie
FergusonJulie@jfprmedia.com(312) 385-0098
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Aug 2024 to Sep 2024
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Sep 2023 to Sep 2024